| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
9,620 |
8,906 |
$2.23M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
6,035 |
5,544 |
$1.46M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
13,374 |
12,890 |
$700K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
20,379 |
18,627 |
$171K |
| 80053 |
Comprehensive metabolic panel |
15,886 |
14,549 |
$161K |
| 59025 |
Fetal non-stress test |
1,058 |
867 |
$154K |
| 71045 |
Radiologic examination, chest; single view |
5,274 |
5,012 |
$141K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
1,105 |
295 |
$129K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
2,079 |
2,017 |
$113K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
162 |
159 |
$93K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
1,598 |
1,497 |
$84K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
4,900 |
4,187 |
$55K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
477 |
267 |
$48K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
1,321 |
1,284 |
$45K |
| G0378 |
Hospital observation service, per hour |
1,322 |
1,118 |
$43K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
599 |
580 |
$30K |
| 86780 |
|
1,332 |
1,297 |
$25K |
| 81001 |
|
8,416 |
7,867 |
$25K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
3,363 |
3,110 |
$23K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
450 |
442 |
$20K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
309 |
297 |
$19K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
427 |
415 |
$18K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
2,032 |
1,940 |
$18K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
761 |
741 |
$18K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
412 |
403 |
$18K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
1,524 |
1,415 |
$17K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
1,745 |
1,711 |
$14K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
277 |
268 |
$13K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
195 |
50 |
$11K |
| 83690 |
|
2,051 |
1,889 |
$11K |
| 84484 |
|
2,213 |
1,725 |
$11K |
| 87486 |
|
162 |
159 |
$10K |
| G0382 |
Level 3 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) |
166 |
163 |
$9K |
| 87581 |
|
162 |
159 |
$8K |
| 86850 |
|
472 |
452 |
$7K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
1,284 |
1,173 |
$7K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
17 |
14 |
$6K |
| 70450 |
Computed tomography, head or brain; without contrast material |
383 |
375 |
$5K |
| 86803 |
|
273 |
267 |
$5K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
98 |
93 |
$5K |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,016 |
970 |
$5K |
| 93976 |
|
45 |
39 |
$4K |
| 82077 |
|
408 |
374 |
$4K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,217 |
1,180 |
$4K |
| G0384 |
Level 5 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) |
414 |
386 |
$4K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
163 |
159 |
$4K |
| 87340 |
|
275 |
269 |
$4K |
| 86787 |
|
182 |
177 |
$3K |
| 86900 |
|
533 |
507 |
$3K |
| 86317 |
|
156 |
153 |
$3K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
1,273 |
1,015 |
$3K |
| G0383 |
Level 4 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) |
231 |
213 |
$3K |
| 83655 |
|
121 |
121 |
$3K |
| 80143 |
|
248 |
223 |
$3K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
27 |
12 |
$2K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
804 |
780 |
$2K |
| 86901 |
|
534 |
507 |
$2K |
| 80179 |
|
233 |
210 |
$2K |
| 71046 |
Radiologic examination, chest; 2 views |
43 |
42 |
$2K |
| 80061 |
Lipid panel |
636 |
632 |
$2K |
| 76801 |
|
17 |
14 |
$2K |
| 31720 |
|
27 |
26 |
$2K |
| 81025 |
|
168 |
153 |
$2K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
52 |
52 |
$1K |
| 94760 |
|
570 |
412 |
$1K |
| 83735 |
|
1,027 |
806 |
$1K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
563 |
557 |
$1K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
685 |
498 |
$1K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
93 |
87 |
$1K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
464 |
438 |
$1K |
| 86762 |
|
38 |
36 |
$918.46 |
| 97597 |
|
19 |
16 |
$883.98 |
| 87420 |
|
47 |
46 |
$880.34 |
| 83880 |
|
315 |
299 |
$878.91 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
117 |
111 |
$763.18 |
| 84702 |
|
74 |
58 |
$747.34 |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
65 |
65 |
$556.86 |
| 87150 |
|
12 |
12 |
$528.04 |
| 82950 |
|
53 |
53 |
$432.65 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
17 |
12 |
$356.29 |
| 87070 |
|
39 |
39 |
$340.75 |
| 85027 |
|
223 |
199 |
$281.82 |
| 83605 |
|
256 |
201 |
$274.39 |
| 87077 |
|
272 |
223 |
$262.80 |
| 87186 |
|
236 |
195 |
$260.74 |
| 89220 |
|
14 |
13 |
$256.28 |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
54 |
50 |
$247.06 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
12 |
12 |
$247.00 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
279 |
258 |
$191.48 |
| 85610 |
|
642 |
528 |
$190.26 |
| 85018 |
|
32 |
32 |
$161.75 |
| 36415 |
Collection of venous blood by venipuncture |
5,509 |
4,713 |
$157.14 |
| 84439 |
|
15 |
15 |
$155.59 |
| J3490 |
Unclassified drugs |
24 |
24 |
$116.10 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
33 |
33 |
$65.58 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
55 |
55 |
$52.49 |
| J7510 |
Prednisolone oral, per 5 mg |
14 |
14 |
$36.13 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
20 |
12 |
$13.69 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
41 |
41 |
$7.21 |
| 85652 |
|
14 |
12 |
$6.70 |
| 87205 |
|
12 |
12 |
$3.59 |
| A9270 |
Non-covered item or service |
384 |
364 |
$0.00 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
55 |
54 |
$0.00 |
| 82962 |
|
917 |
284 |
$0.00 |
| J2704 |
Injection, propofol, 10 mg |
26 |
26 |
$0.00 |